Powered by: Motilal Oswal
2025-12-22 10:37:01 am | Source: Accord Fintech
Krishna Institute of Medical shines on entering into agreement with Andhra Mahila Sabha
Krishna Institute of Medical shines on entering into agreement with Andhra Mahila Sabha

Krishna Institute of Medical Sciences is currently trading at Rs. 653.90, up by 14.30 points or 2.24% from its previous closing of Rs. 639.60 on the BSE.

The scrip opened at Rs. 657.65 and has touched a high and low of Rs. 662.65 and Rs. 645.40 respectively. So far 17160 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 798.00 on 24-Jul-2025 and a 52 week low of Rs. 474.55 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 674.10 and Rs. 632.05 respectively. The current market cap of the company is Rs. 26181.09 crore.

The promoters holding in the company stood at 34.11%, while Institutions and Non-Institutions held 47.15% and 18.74% respectively.

Krishna Institute of Medical Sciences has entered into a Leave and License Agreement with Andhra Mahila Sabha for taking land admeasuring approximately 1.168 acres (equivalent to 21.19 Grounds) located at Chennai, Tamil Nadu on a long term lease for setting up a Super Speciality Hospital. The investment in the project is expected to be around Rs 300 crore. 

This proposed capacity expansion represents a significant strategic milestone, establishing the company’s maiden presence in Tamil Nadu and is expected to drive improved operational performance and sustainable long-term financial returns. 

Krishna Institute of Medical Sciences is one of the largest corporate healthcare groups in AP and Telangana in terms of number of patients treated and treatments offered.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here